HPV-16 E2 contributes to induction of HPV-16 late gene expression by inhibiting early polyadenylation

EMBO Journal

Volumn 31, Issue 14, 2012, Pages 3212-3227

  Johansson, Cecilia ^a   Somberg, Monika ^b   Li, Xiaoze ^a   Backström Winquist, Ellenor ^a   Fay, Joanna ^c   Ryan, Fergus ^d   Pim, David ^e   Banks, Lawrence ^e   Schwartz, Stefan ^a  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^d DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^e INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

E2; HPV; papillomavirus; polyadenylation; splicing

Indexed keywords

HUMAN PAPILLOMAVIRUS TYPE 16 E2 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; NONHUMAN; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

CAPSID PROTEINS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, VIRAL; HELA CELLS; HUMAN PAPILLOMAVIRUS 16; HUMANS; ONCOGENE PROTEINS, VIRAL; POLYADENYLATION; REPRESSOR PROTEINS; RNA 3' POLYADENYLATION SIGNALS; RNA, VIRAL;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 84864126434     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2012.147     Document Type: Article

References (81)

1. Androphy EJ, Lowy DR, Schiller JT (1987) Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature 325: 70-73 (Pubitemid 17059472)
2. Backström Winquist E, Abdurahman S, Tranell A, Lindström S, Tingsborg S, Schwartz S (2012) Inefficient splicing of segment 7 and 8 mRNAs is an inherent property of influenza virus A/Brevig Mission/1918/1 (H1N1) that causes elevated expression of NS1 protein. Virology 422: 46-58
3. Baker C, Calef C (1997) Maps of papillomavirus mRNA transcripts. In Human Papillomaviruses: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences, Billakanti SR, Calef CE, Farmer AD, Halpern AL, Myers GL (eds). Los Alamos: Los Alamos National Library
4. Baxter MK, McPhillips MG, Ozato K, McBride AA (2005) The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4. J Virol 79: 4806-4818 (Pubitemid 40464231)
5. Bedrosian CL, Bastia D (1990) The DNA-binding domain of HPV-16 E2 protein interaction with the viral enhancer: protein-induced DNA bending and role of the nonconserved core sequence in binding site affinity. Virology 174: 557-575 (Pubitemid 20060158)
6. Blachon S, Bellanger S, Demeret C, Thierry F (2005) Nucleocytoplasmic shuttling of high risk human Papillomavirus E2 proteins induces apoptosis. J Biol Chem 280: 36088-36098 (Pubitemid 41633880)
7. Bodaghi S, Jia R, Zheng ZM (2009) Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites. Virology 386: 32-43
8. Bodily J, Laimins LA (2011) Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol 19: 33-39
9. Chow LT, Broker TR, Steinberg BM (2010) The natural history of human papillomavirus infections of the mucosal epithelia. APMIS 118: 422-449
10. Collier B, Oberg D, Zhao X, Schwartz S (2002) Specific inactivation of inhibitory sequences in the 50 end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells. J Virol 76: 2739-2752 (Pubitemid 34184860)
11. Dai W, Zhang G, Makeyev EV (2012) RNA-binding protein HuR autoregulates its expression by promoting alternative polyadenylation site usage. Nucleic Acids Res 40: 787-800
12. Davy C, McIntosh P, Jackson DJ, Sorathia R, Miell M,Wang Q, Khan J, Soneji Y, Doorbar J (2009) A novel interaction between the human papillomavirus type 16 E2 and E1-E4 proteins leads to stabilization of E2. Virology 394: 266-275
13. Day PM, Roden RB, Lowy DR, Schiller JT (1998) The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. J Virol 72: 142-150 (Pubitemid 28048822)
14. Deng W, Jin G, Lin BY, Van Tine BA, Broker TR, Chow LT (2003) mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication. J Virol 77: 10213-10226 (Pubitemid 37129665)
15. Dong G, Broker TR, Chow LT (1994) Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements. J Virol 68: 1115-1127 (Pubitemid 24022216)
16. Doorbar J (2005) The papillomavirus life cycle. J Clin Virol 32(Suppl 1): S7-S15 (Pubitemid 40332584)
17. Gammoh N, Grm HS, Massimi P, Banks L (2006) Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator. J Virol 80: 1787-1797 (Pubitemid 43228719)
18. Giri I, Yaniv M (1988) Structural and mutational analysis of E2 trans-activating proteins of papillomaviruses reveals three distinct functional domains. EMBO J 7: 2823-2829
19. Graham SV (2010) Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies. Future Microbiol 5: 1493-1506
20. Grm HS, Massimi P, Gammoh N, Banks L (2005) Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein. Oncogene 24: 5149-5164 (Pubitemid 41192432)
21. Heino P, Zhou J, Lambert PF (2000) Interaction of the papillomavirus transcription/replication factor, E2, and the viral capsid protein, L2. Virology 276: 304-314
22. Hibma MH, Raj K, Ely SJ, Stanley M, Crawford L (1995) The interaction between human papillomavirus type 16 E1 and E2 proteins is blocked by an antibody to the N-terminal region of E2. Eur J Biochem 229: 517-525
23. Howley PM, Lowy DR (2006) Papillomaviridae. In Virology, Knipe DM, Howley PM (eds) Vol. 25th edn 62, pp 2299-2354. Philadelphia, PALippincott/The Williams & Wilkins Co
24. Hubert WG, Laimins LA (2002) Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression. J Virol 76: 2263-2273 (Pubitemid 34150694)
25. Ilves I, Maemets K, Silla T, Janikson K, Ustav M (2006) Brd4 is involved in multiple processes of the bovine papillomavirus type 1 life cycle. J Virol 80: 3660-3665
26. Johansson C, Graham SV, Dornan ES, Morgan IM (2009) The human papillomavirus 16 E2 protein is stabilised in S phase. Virology 394: 194-199
27. Johansson C, Somberg M, Schwartz S (2010) Proteins involved in HPV-16 pre-mRNA processing. Curr Top Virol 8: 17-27
28. Johansson C, Zhao H, Bajak E, Granberg F, Pettersson U, Svensson C (2005) Impact of the interaction between adenovirus E1A and CtBP on host cell gene expression. Virus Res 113: 51-63 (Pubitemid 41219555)
29. Kadaja M, Silla T, Ustav E, Ustav M (2009) Papillomavirus DNA replication-from initiation to genomic instability. Virology 384: 360-368
30. Kadaja M, Sumerina A, Verst T, Ojarand M, Ustav E, Ustav M (2007) Genomic instability of the host cell induced by the human papillomavirus replication machinery. EMBO J 26: 2180-2191 (Pubitemid 46625800)
31. Kanopka A, Muhlemann O, Akusjarvi G (1996) Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA. Nature 381: 535-538 (Pubitemid 26170934)
32. Kanopka A, Muhlemann O, Petersen-Mahrt S, Estmer C, Ohrmalm C, Akusjarvi G (1998) Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins. Nature 393: 185-187 (Pubitemid 28242261)
33. Kurg R, Uusen P, Vosa L, Ustav M (2010) Human papillomavirus E2 protein with single activation domain initiates HPV18 genome replication, but is not sufficient for long-term maintenance of virus genome. Virology 408: 159-166
34. Lace MJ, Anson JR, Thomas GS, Turek LP, Haugen TH (2008) The E8-E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes. J Virol 82: 10841-10853 (Pubitemid 352691200)
35. Lai MC, Teh BH, Tarn WY (1999) A human papillomavirus E2 transcriptional activator. The interactions with cellular splicing factors and potential function in pre-mRNA processing. J Biol Chem 274: 11832-11841
36. Li R, Knight J, Bream G, Stenlund A, Botchan M (1989) Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. Genes Dev 3: 510-526
37. Lou H, Neugebauer KM, Gagel RF, Berget SM (1998) Regulation of alternative polyadenylation by U1 snRNPs and SRp20. Mol Cell Biol 18: 4977-4985 (Pubitemid 28388080)
38. McBride AA (2008) Replication and partitioning of papillomavirus genomes. Adv Virus Res 72: 155-205
39. McBride AA, Oliveira JG, McPhillips MG (2006) Partitioning viral genomes in mitosis: same idea, different targets. Cell Cycle 5: 1499-1502 (Pubitemid 44091967)
40. McPhillips MG, Oliveira JG, Spindler JE, Mitra R, McBride AA (2006) Brd4 is required for E2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J Virol 80: 9530-9543 (Pubitemid 44435629)
41. Mole S, Milligan SG, Graham SV (2009) Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF. J Virol 83: 357-367
42. Muhlemann O, Akusjarvi G (2007) Preparation of soluble extracts from adenovirus-infected cells for studies of RNA splicing. Methods Mol Med 131: 33-46
43. Nakahara T, Peh WL, Doorbar J, Lee D, Lambert PF (2005) Human papillomavirus type 16 E1circumflexE4 contributes to multiple facets of the papillomavirus life cycle. J Virol 79: 13150-13165 (Pubitemid 41433233)
44. Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM (1998) Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 30end formation of cellular premRNAs. Mol Cell 1: 991-1000 (Pubitemid 128379260)
45. Noah DL, Twu KY, Krug RM (2003) Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 30 end processing of cellular pre-mRNAS. Virology 307: 386-395 (Pubitemid 36344169)
46. Oberg D, Collier B, Zhao X, Schwartz S (2003) Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells. J Virol 77: 11674-11684 (Pubitemid 37271666)
47. Oberg D, Fay J, Lambkin H, Schwartz S (2005) A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H. J Virol 79: 9254-9269 (Pubitemid 40934837)
48. Okoye A, Cordano P, Taylor ER, Morgan IM, Everett R, Campo MS (2005) Human papillomavirus 16 L2 inhibits the transcriptional activation function, but not the DNA replication function, of HPV-16 E2. Virus Res 108: 1-14 (Pubitemid 40170328)
49. Parish JL, Bean AM, Park RB, Androphy EJ (2006) ChlR1 is required for loading papillomavirus E2 onto mitotic chromosomes and viral genome maintenance. Mol Cell 24: 867-876 (Pubitemid 44960091)
50. Piccini A, Storey A, Romanos M, Banks L (1997) Regulation of human papillomavirus type 16 DNA replication by E2, glucocorticoid hormone and epidermal growth factor. J Gen Virol 78(Part 8): 1963-1970 (Pubitemid 27367682)
51. Pim D, Massimi P, Dilworth SM, Banks L (2005) Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A. Oncogene 24: 7830-7838 (Pubitemid 41715189)
52. Rush M, Zhao X, Schwartz S (2005) A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression. J Virol 79: 12002-12015 (Pubitemid 41279317)
53. Schwartz S (2008) HPV-16 RNA processing. Front Biosci 13: 5880-5891
54. Schweiger MR, Ottinger M, You J, Howley PM (2007) Brd4-independent transcriptional repression function of the papillomavirus E2 proteins. J Virol 81: 9612-9622 (Pubitemid 350067667)
55. Shtrichman R, Sharf R, Barr H, Dobner T, Kleinberger T (1999) Induction of apoptosis by adenovirus E4orf4 protein is specific to transformed cells and requires an interaction with protein phosphatase 2A. Proc Natl Acad Sci USA 96: 10080-10085 (Pubitemid 29422515)
56. Skolnik-David H, Moore CL, Sharp PA (1987) Electrophoretic separation of polyadenylation-specific complexes. Genes Dev 1: 672-682
57. Smith JA, White EA, Sowa ME, Powell ML, Ottinger M, Harper JW, Howley PM (2010) Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. Proc Natl Acad Sci USA 107: 3752-3757
58. Somberg M, Rush M, Fay J, Ryan F, Lambkin H, Akusjarvi G, Schwartz S (2009) Adenovirus E4orf4 induces HPV-16 late L1 mRNA production. Virology 383: 279-290
59. Somberg M, Schwartz S (2010) Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 30-splice site on the HPV-16 genome. J Virol 84: 8219-8230
60. Somberg M, Zhao X, Frohlich M, Evander M, Schwartz S (2008) Polypyrimidine tract binding protein induces human papillomavirus type 16 late gene expression by interfering with splicing inhibitory elements at the major late 50 splice site, SD3632. J Virol 82: 3665-3678 (Pubitemid 351429942)
61. Stenlund A (2003) Initiation of DNA replication: lessons from viral initiator proteins. Nat Rev Mol Cell Biol 4: 777-785 (Pubitemid 37229374)
62. Stubenrauch F, Lim HB, Laimins LA (1998) Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31. J Virol 72: 1071-1077 (Pubitemid 28116886)
63. Takagaki Y, Manley JL, MacDonald CC, Wilusz J, Shenk T (1990) A multisubunit factor, CstF, is required for polyadenylation of mammalian pre-mRNAs. Genes Dev 4: 2112-2120 (Pubitemid 120034518)
64. Terhune SS, Hubert WG, Thomas JT, Laimins LA (2001) Early polyadenylation signals of human papillomavirus type 31 negatively regulate capsid gene expression. J Virol 75: 8147-8157 (Pubitemid 32743687)
65. Terhune SS, Milcarek C, Laimins LA (1999) Regulation of human papillomavirus type 31 polyadenylation during the differentiation-dependent life cycle. J Virol 73: 7185-7192 (Pubitemid 29383199)
66. Thierry F (2009) Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma. Virology 384: 375-379
67. Valente ST, Gilmartin GM, Venkatarama K, Arriagada G, Goff SP (2009) HIV-1 mRNA 30 end processing is distinctively regulated by eIF3f, CDK11, and splice factor 9G8. Mol Cell 36: 279-289
68. Wang HK, Duffy AA, Broker TR, Chow LT (2009) Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev 23: 181-194
69. Wilson R, Fehrmann F, Laimins LA (2005) Role of the E1-E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31. J Virol 79: 6732-6740 (Pubitemid 40677304)
70. Wilson R, Ryan GB, Knight GL, Laimins LA, Roberts S (2007) The full-length E1E4 protein of human papillomavirus type 18 modulates differentiation-dependent viral DNA amplification and late gene expression. Virology 362: 453-460 (Pubitemid 46678156)
71. Wu SY, Lee AY, Hou SY, Kemper JK, Erdjument-Bromage H, Tempst P, Chiang CM (2006) Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev 20: 2383-2396 (Pubitemid 44320387)
72. Xue Y, Bellanger S, Zhang W, Lim D, Low J, Lunny D, Thierry F (2010) HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma. Cancer Res 70: 5316-5325
73. Yan J, Li Q, Lievens S, Tavernier J, You J (2010) Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repression. J Virol 84: 76-87
74. You J, Croyle JL, Nishimura A, Ozato K, Howley PM (2004) Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117: 349-360 (Pubitemid 38534541)
75. Zhao X, Fay J, Lambkin H, Schwartz S (2007) Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers. Virology 369: 351-363 (Pubitemid 350087190)
76. Zhao X, Oberg D, Rush M, Fay J, Lambkin H, Schwartz S (2005) A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein. J Virol 79: 4270-4288 (Pubitemid 40388365)
77. Zhao X, Rush M, Schwartz S (2004) Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene. J Virol 78: 10888-10905 (Pubitemid 39299629)
78. Zheng G, Schweiger MR, Martinez-Noel G, Zheng L, Smith JA, Harper JW, Howley PM (2009) Brd4 regulation of papillomavirus protein E2 stability. J Virol 83: 8683-8692
79. Zheng ZM, Baker CC (2006) Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci 11: 2286-2302 (Pubitemid 43822560)
80. Zhu H, Zhou HL, Hasman RA, Lou H (2007) Hu proteins regulate polyadenylation by blocking sites containing U-rich sequences. J Biol Chem 282: 2203-2210 (Pubitemid 47076748)
81. zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350 (Pubitemid 37328947)